| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Acquisition of treasury stock | 23,038 | - |
| Net cash used in financing activities | -34,904 | -7,079 |
| Net (decrease) increase in cash and cash equivalents | -41,762 | -12,862 |
| Cash and cash equivalents at beginning of period | 103,147 | - |
| Cash and cash equivalents at end of period | 61,385 | - |
ADMA BIOLOGICS, INC. (ADMA)
ADMA BIOLOGICS, INC. (ADMA)